BOSTON BIO SYSTEMS LTD. Fair Value
BOSTON BIO SYSTEMS LTD. (BOSTONBIO) average fair value is ₹6.84 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹5.39 (+26.9%), fair value range ₹3.85–₹8.57. See BOSTONBIO book value to compare market price against book value per share.
Fair Value Analysis Export
BOSTONBIO Fair Value vs Current Price — Valuation Summary
BOSTONBIO average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit BOSTON BIO SYSTEMS LTD. share price today.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
BOSTONBIO Fair Value Analysis — Data Sources & Coverage
BOSTON BIO SYSTEMS LTD. financial data sources, valuation methods applied and sector benchmarks used. Also explore BOSTONBIO share price data to track price trends across different timeframes.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
BOSTONBIO vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
BOSTON BIO SYSTEMS LTD. P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| One Global Service Provi… | ONEGLOBAL | 14.58 | 7.17 | ₹1,064 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
| Apollo Hospitals | APOLLOHOSP | 59.23 | 12.52 | ₹119,406 |
| Gujarat Kidney and Super… | GKSL | 83.28 | 3.9 | ₹1,117 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.